AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Profit After Tax History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit After Tax | ₹3,484 Cr | ₹3,169 Cr | ₹1,928 Cr | ₹2,647 Cr | ₹5,334 Cr |
What is the latest Profit After Tax of AUROBINDO PHARMA ?
Year | Profit After Tax |
---|---|
Mar2025 | ₹3,484 Cr |
Mar2024 | ₹3,169 Cr |
Mar2023 | ₹1,928 Cr |
Mar2022 | ₹2,647 Cr |
Mar2021 | ₹5,334 Cr |
How is Profit After Tax of AUROBINDO PHARMA Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹3,484 Cr | 9.93 | |
Mar2024 | ₹3,169 Cr | 64.40 | |
Mar2023 | ₹1,928 Cr | -27.18 | |
Mar2022 | ₹2,647 Cr | -50.37 | |
Mar2021 | ₹5,334 Cr | - |
Compare Profit After Tax of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹63,394.3 Cr | -3.3% | 2.3% | -25.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,348.0 Cr | -1.3% | -1.8% | -12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,840.0 Cr | -2% | -4.2% | 11% | Stock Analytics | |
CIPLA | ₹124,222.0 Cr | -2.6% | -4% | -6.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,346.0 Cr | 1.4% | -1.5% | 5.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,437.0 Cr | -1.8% | 1.1% | -0.2% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -3.3% |
2.3% |
-25.8% |
SENSEX | -1.2% |
0.5% |
-1.8% |
You may also like the below Video Courses